Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis

Byoung Chul Cho, Y. Ohe, C. Zhou, T. Reungwetwattana, Y. Cheng, B. Chewaskulyong, K.H. Lee, D. Planchard, J.F. Vansteenkiste, J.E. Gray, R. Shah, P.K. Cheema, M. Tiseo, T. John, R. Hodge, Y. Rukazenkov, J.-C. Soria, M.-C. Lin, F. Imamura, S.S. Ramalingam
Annals of Oncology
November 1, 2019
10.1093/annonc/mdz446.015
Cited by 11Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis